Evidence map›Paper›PMID 24492643›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2014

Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania.

Aldona Mikaliūkštienė, Kęstutis Žagminas, Algirdas Juozulynas, Laura Narkauskaitė, Jonas Sąlyga, Konstancija Jankauskienė, Rimantas Stukas, Genė Šurkienė

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Improvement of Glycemic Control in Insulin-Dependent Diabetics with Depression by Concomitant Treatment with Antidepressants.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Depression in Diabetes-The Hidden Bane.Annals of neurosciences · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aldona MikaliūkštienėFaculty of Medicine, Vilnius University, Vilnius, Lithuania.
Kęstutis ŽagminasFaculty of Medicine, Vilnius University, Vilnius, Lithuania.
Algirdas JuozulynasDepartment of Innovative Diagnostic, Treatment and Health Technology, Institute of Innovative Medicine, Vilnius, Lithuania.
Laura NarkauskaitėResearch and Technology Assassment, Institute of Hygiene, Vilnius, Lithuania.
Jonas SąlygaFaculty of Health Science, University of Klaipėda, Klaipėda, Lithuania.
Konstancija JankauskienėAcademy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Rimantas StukasFaculty of Medicine, Vilnius University, Vilnius, Lithuania.
Genė ŠurkienėFaculty of Medicine, Vilnius University, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepression is associated with a variety of diabetes complications, including diabetic retinopathy, nephropathy, neuropathy, and macrovascular complications. The prevalence of the symptoms of anxiety (32%) and depression (22.4%) in patients with diabetes is considerably higher than in general population samples (10%). The aim of this study was to evaluate the prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes (T2DM). MATERIAL AND

methodsThis survey was conducted during 2007-2010. In total, 1500 patients were invited to participate in the study. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety for the evaluation of the depressive state and anxiety. Statistical analysis was carried out using SPSS 17.0.

resultsMore than 70% of all respondents who participated in the study had diabetes mellitus complications (72.2%). The prevalence of mild to severe depression score was 28.5% (95% CI 25.7-31.4). The prevalence of anxiety was 42.4% (95% CI 39.3-45.5). Anxiety was more frequent among females (46.8%) than among males (34.7%) (p<0.001). A significant negative trend was observed between prevalence of anxiety and depression, and age and education (p for trend <0.001).

conclusionsA significant association between depression and diabetic complications was identified (p<0.05). Duration of diabetes was a risk factor significantly associated with higher scores of anxiety among the patients with T2DM.

Indexed as

AdultAgedAnxietyDepressionDiabetes Mellitus, Type 2Epidemiologic FactorsFemaleHumansLithuaniaMaleMiddle AgedPrevalence

Identifiers

PMID24492643
PMCPMC3930682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.